Shantell Laketa Heiber

Array ( [id] => 5416358 [patent_doc_number] => 20090042245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Methods of overexpression and recovery of porcine circovirus type 2 ORF2' [patent_app_type] => utility [patent_app_number] => 11/034797 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6535 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042245.pdf [firstpage_image] =>[orig_patent_app_number] => 11034797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694091 [patent_doc_number] => 20060154238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'COMPOUNDS AND METHODS OF EARLY DIAGNOSIS OF CERVICAL CANCER AND GENITAL CONDYLOMA WITH HPV, CHSP60 TUMOR SUPPRESSOR H-RAS, K-RAS AND PTEN DERIVED PEPTIDES MODIFIED' [patent_app_type] => utility [patent_app_number] => 10/905527 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23190 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154238.pdf [firstpage_image] =>[orig_patent_app_number] => 10905527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 916587 [patent_doc_number] => 07323178 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-01-29 [patent_title] => 'Method of identification of equine herpes virus type 1 causing neurological disease, method of producing a vaccine against neurological disease caused by equine herpes virus type 1, and vaccine against neurological disease caused by equine herpes virus type 1' [patent_app_type] => utility [patent_app_number] => 11/027151 [patent_app_country] => US [patent_app_date] => 2004-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2189 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323178.pdf [firstpage_image] =>[orig_patent_app_number] => 11027151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655830 [patent_doc_number] => 20060141566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Virus preparations and methods' [patent_app_type] => utility [patent_app_number] => 11/021275 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2922 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141566.pdf [firstpage_image] =>[orig_patent_app_number] => 11021275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252143 [patent_doc_number] => 20050142541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Antibodies for oncogenic strains of HPV and methods of their use' [patent_app_type] => utility [patent_app_number] => 11/021949 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19407 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142541.pdf [firstpage_image] =>[orig_patent_app_number] => 11021949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905161 [patent_doc_number] => 20050100556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Chimeric papillomavirus-like particles' [patent_app_type] => utility [patent_app_number] => 11/022091 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7593 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100556.pdf [firstpage_image] =>[orig_patent_app_number] => 11022091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 902119 [patent_doc_number] => 07335356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein' [patent_app_type] => utility [patent_app_number] => 11/013996 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14905 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335356.pdf [firstpage_image] =>[orig_patent_app_number] => 11013996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 541118 [patent_doc_number] => 07166435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Compositions and methods for reducing the transmissivity of illnesses' [patent_app_type] => utility [patent_app_number] => 11/012764 [patent_app_country] => US [patent_app_date] => 2004-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20327 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166435.pdf [firstpage_image] =>[orig_patent_app_number] => 11012764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925407 [patent_doc_number] => 20050238662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Circovirus sequences associated with piglet weight loss disease (PWD)' [patent_app_type] => utility [patent_app_number] => 11/007798 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23910 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238662.pdf [firstpage_image] =>[orig_patent_app_number] => 11007798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880860 [patent_doc_number] => 20060029943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer' [patent_app_type] => utility [patent_app_number] => 11/006468 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11717 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029943.pdf [firstpage_image] =>[orig_patent_app_number] => 11006468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019276 [patent_doc_number] => 20050221295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Peptides from the E7 protein of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papilloma virus associated cancers' [patent_app_type] => utility [patent_app_number] => 10/995902 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7171 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221295.pdf [firstpage_image] =>[orig_patent_app_number] => 10995902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988125 [patent_doc_number] => 20070154464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell' [patent_app_type] => utility [patent_app_number] => 10/595840 [patent_app_country] => US [patent_app_date] => 2004-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23212 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154464.pdf [firstpage_image] =>[orig_patent_app_number] => 10595840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 344850 [patent_doc_number] => 07498036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Optimized expression of HPV 58 L1 in yeast' [patent_app_type] => utility [patent_app_number] => 10/579111 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8300 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498036.pdf [firstpage_image] =>[orig_patent_app_number] => 10579111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7176274 [patent_doc_number] => 20050123562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Novel composition' [patent_app_type] => utility [patent_app_number] => 10/983451 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8869 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123562.pdf [firstpage_image] =>[orig_patent_app_number] => 10983451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925406 [patent_doc_number] => 20050238661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof' [patent_app_type] => utility [patent_app_number] => 10/977375 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9247 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238661.pdf [firstpage_image] =>[orig_patent_app_number] => 10977375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7262950 [patent_doc_number] => 20050144657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'RhPV as a model for HPV-induced cancers' [patent_app_type] => utility [patent_app_number] => 10/978239 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14112 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20050144657.pdf [firstpage_image] =>[orig_patent_app_number] => 10978239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966036 [patent_doc_number] => 20050232933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'CMV-IE1 peptides and method of use' [patent_app_type] => utility [patent_app_number] => 10/953769 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17737 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232933.pdf [firstpage_image] =>[orig_patent_app_number] => 10953769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921449 [patent_doc_number] => 20060240040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Optimized expression of hpv 45 l1 in yeast' [patent_app_type] => utility [patent_app_number] => 10/573330 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7998 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240040.pdf [firstpage_image] =>[orig_patent_app_number] => 10573330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097673 [patent_doc_number] => 20050130132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Compositions and methods for the diagnosis and treatment of herpes simplex virus infection' [patent_app_type] => utility [patent_app_number] => 10/945050 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44632 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130132.pdf [firstpage_image] =>[orig_patent_app_number] => 10945050 [rel_patent_id] =>[rel_patent_doc_number] =>)